JP2022534119A5 - - Google Patents

Info

Publication number
JP2022534119A5
JP2022534119A5 JP2021570851A JP2021570851A JP2022534119A5 JP 2022534119 A5 JP2022534119 A5 JP 2022534119A5 JP 2021570851 A JP2021570851 A JP 2021570851A JP 2021570851 A JP2021570851 A JP 2021570851A JP 2022534119 A5 JP2022534119 A5 JP 2022534119A5
Authority
JP
Japan
Application number
JP2021570851A
Other languages
Japanese (ja)
Other versions
JP2022534119A (ja
JPWO2020243706A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/035558 external-priority patent/WO2020243706A1/en
Publication of JP2022534119A publication Critical patent/JP2022534119A/ja
Publication of JP2022534119A5 publication Critical patent/JP2022534119A5/ja
Publication of JPWO2020243706A5 publication Critical patent/JPWO2020243706A5/ja
Pending legal-status Critical Current

Links

JP2021570851A 2019-05-30 2020-06-01 組換えヘルペスウイルスベクター Pending JP2022534119A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962854637P 2019-05-30 2019-05-30
US62/854,637 2019-05-30
US201962873094P 2019-07-11 2019-07-11
US62/873,094 2019-07-11
PCT/US2020/035558 WO2020243706A1 (en) 2019-05-30 2020-06-01 Recombinant herpesvirales vector

Publications (3)

Publication Number Publication Date
JP2022534119A JP2022534119A (ja) 2022-07-27
JP2022534119A5 true JP2022534119A5 (https=) 2023-06-09
JPWO2020243706A5 JPWO2020243706A5 (https=) 2023-06-09

Family

ID=71787155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570851A Pending JP2022534119A (ja) 2019-05-30 2020-06-01 組換えヘルペスウイルスベクター

Country Status (10)

Country Link
US (1) US20220307052A1 (https=)
EP (1) EP3976806A1 (https=)
JP (1) JP2022534119A (https=)
KR (1) KR20220016150A (https=)
CN (1) CN114207120A (https=)
AU (1) AU2020284255A1 (https=)
CA (1) CA3142194A1 (https=)
IL (1) IL288419A (https=)
SG (1) SG11202113052YA (https=)
WO (1) WO2020243706A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114787179A (zh) * 2019-10-10 2022-07-22 坚固生物科技公司 经修饰的aav衣壳及其用途
EP3950948A1 (en) * 2020-08-07 2022-02-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Platform vector for modular and simplified insertion of transgenes into alphaherpesvirinae
WO2022067038A1 (en) * 2020-09-25 2022-03-31 President And Fellows Of Harvard College Immunotherapeutic virus for the treatment of cancer
US20240191251A1 (en) * 2021-04-05 2024-06-13 Solid Biosciences Inc. Recombinant herpesvirales vector
AU2022373653A1 (en) 2021-10-18 2024-05-02 Regeneron Pharmaceuticals, Inc. Eukaryotic cells comprising adenovirus-associated virus polynucleotides
CN114703327B (zh) * 2022-03-29 2024-11-26 广西壮族自治区兽医研究所 检测鸡传染性喉气管炎病毒的组合物及其应用
CN115927473B (zh) * 2022-07-15 2024-06-18 上海本导基因技术有限公司 一种用于单纯疱疹病毒感染性疾病的基因治疗药物
CN120435565A (zh) * 2022-12-01 2025-08-05 免疫医疗有限责任公司 腺相关病毒生产平台
CN116286924A (zh) * 2023-01-06 2023-06-23 齐鲁动物保健品有限公司 一种猫疱疹病毒ⅰ型感染性克隆质粒及其构建

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9700411D0 (en) * 1997-01-10 1997-02-26 Univ London Eukaryotic gene expression cassette and uses thereof
US20040063094A1 (en) * 1998-05-20 2004-04-01 Biovex Limited Mutant herpes simplex viruses and uses thereof
ATE437944T1 (de) 2000-04-28 2009-08-15 Asklepios Biopharmaceutical In Für das dystrophin-minigen kodierende dna- sequenzen und verfahren zu deren verwendung
ATE400656T1 (de) 2000-10-06 2008-07-15 Univ Michigan Mini-dystrophin nukleinsäure- und peptidsequenzen
GB0208390D0 (en) * 2002-04-11 2002-05-22 Univ London Adeno-associated virus producer system
CN1856576B (zh) 2003-09-30 2011-05-04 宾夕法尼亚州立大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
JP5575486B2 (ja) 2007-01-18 2014-08-20 ユニヴァーシティ オブ ミズーリー−コロンビア 筋鞘にnNOSを回復させる合成ミニ/ミクロジストロフィン遺伝子
EP2960336A1 (en) 2014-06-27 2015-12-30 Genethon Efficient systemic treatment of dystrophic muscle pathologies
IL286316B2 (en) 2015-01-16 2023-03-01 Univ Washington New micro-dystrophins and related method of use
MX2019011046A (es) * 2017-03-17 2019-10-17 Res Inst Nationwide Childrens Hospital Administracion de vectores del virus adenoasociado de microdistrofina especifica del musculo para tratar la distrofia muscular.

Similar Documents

Publication Publication Date Title
JP2022534119A5 (https=)
CN305689639S (https=)
CN305682035S (https=)
CN305535258S (https=)
CN305533390S (https=)
CN305554300S (https=)
CN305532092S (https=)
CN305531851S (https=)
CN305530169S (https=)
CN305529093S (https=)
CN305593888S (https=)
CN305527616S (https=)
CN305553353S (https=)
CN305527353S (https=)
CN305545235S (https=)
CN305779448S (https=)
CN305777836S (https=)
CN305777824S (https=)
CN305776527S (https=)
CN305776258S (https=)
CN305776069S (https=)
CN305761148S (https=)
CN305760456S (https=)
CN305760122S (https=)
CN305758737S (https=)